Suzetrigine Intermediates: A Buyer’s Guide to Journavx Precursors
Suzetrigine (Journavx) is the first non-opioid pain drug approved in 27 years. This guide covers its synthesis route, four chiral centers, key intermediates, and what buyers need to check before sourcing.
